Large-scale roll out of electronic longitudinal mood-monitoring for research in affective disorders: Report from the UK bipolar disorder research network by Gordon-Smith, Katherine et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/118836/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Gordon-Smith, Katherine, Saunders, Kate, Geddes, John R, Harrison, Paul J, Hinds, Chris,
Craddock, Nick, Jones, Ian and Jones, Lisa 2019. Large-scale roll out of electronic longitudinal
mood-monitoring for research in affective disorders: Report from the UK bipolar disorder research
network. Journal of Affective Disorders 246 , pp. 789-793. 10.1016/j.jad.2018.12.099 file 
Publishers page: http://dx.doi.org/10.1016/j.jad.2018.12.099
<http://dx.doi.org/10.1016/j.jad.2018.12.099>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
Large-scale roll out of electronic longitudinal mood-monitoring for research 
in affective disorders: Report from the UK bipolar disorder research network 
 
Katherine Gordon-Smith a, Kate Saunders b, John R Geddes b, Paul J Harrison b, Chris Hinds 
b, Nick Craddock c, Ian Jones c, Lisa Jones a, 
 
a Psychological Medicine, University of Worcester, Henwick Grove, Worcester, WR2 6AJ, UK 
b Department of Psychiatry, University of Oxford, UK and Oxford Health NHS Foundation 
Trust, Warneford Hospital, Oxford, UK 
c National Centre for Mental Health, Cardiff University, UK 
 
ABSTRACT 
Background: Electronic longitudinal mood monitoring has been shown to be acceptable to 
patients with affective disorders within clinical settings, but its use in large-scale research 
has not yet been established. 
Methods: Using both postal and email invitations, we invited 4080 past research 
participants with affective disorders who were recruited into the Bipolar Disorder Research 
Network (BDRN) over a 10 year period to participate in online weekly mood monitoring. In 
addition, since January 2015 we have invited all newly recruited BDRN research participants 
to participate in mood monitoring at the point they were recruited into BDRN. 
Results: Online mood monitoring uptake among past participants was 20%, and among new 
participants to date was 46% with participants recruited over the last year most likely to 
register (61%). More than 90% mood monitoring participants engaged for at least one 
month, with mean engagement period greater than one year (58 weeks) and maximum 
engagement for longer than three years (165 weeks). There were no significant differences 
in the proportion of past and new BDRN participants providing data for at least 4 weeks 
(91%, 92% respectively), 3 months (78%, 82%), 6 months (65%, 54%) or one year (51%, 
44%). 
Limitations: Our experiences with recruiting participants for electronic prospective mood 
monitoring may not necessarily generalise fully to research situations that are very different 
from those we describe. 
Conclusions: Large-scale electronic longitudinal mood monitoring in affective disorders for 
research purposes is feasible with uptake highest among newly recruited participants. 
 
1. Introduction 
Clinical assessment of the subjective experience of mood symptoms in individuals 
with affective disorders has traditionally relied on retrospective techniques, whereby 
patients are asked to recall their experience of the presence/absence, severity and 
fluctuation of mood symptoms often weeks or months later. For researchers 
attempting to measure lifetime course of affective illness, semi structured interviews 
are mainly used which require participants to try to accurately remember mood 
episodes and symptoms that may have occurred many years previously. Such 
methods pose a significant risk of unreliable and biased recall and are thus limited in 
their ability to accurately identify long-term patterns of mood variability. The 
emergence of new technologies has led to vast improvements in the methods used 
for capturing real-time mood data and a number of studies have reported on the 
feasibility of technology-driven mood monitoring in clinical samples of individuals 
with affective disorders (Ortiz and Grof, 2016). 
 
Initial evidence suggests high levels of acceptability and feasibility of ongoing mood 
monitoring of patients with affective disorders within clinical settings. For example, 
Bopp et al. (2010) demonstrated the utility of the University of Oxford's True Colours 
digital mood monitoring system within 62 adult outpatients with bipolar I and 
bipolar II disorder. They reported an overall compliance rate of 75% over an average 
of 36 weeks, suggesting that the system was readily adopted by the clinical 
population. However, it is currently unknown how effectively such electronic mood 
monitoring methods can be implemented within large research cohorts in which no 
clinical feedback is provided. 
 
Here, we report on our experience of implementing online longitudinal mood 
monitoring within the UK Bipolar Disorder Research Network (BDRN; 
www.bdrn.org). We aimed to roll out mood monitoring to a large previously 
recruited sample of 4285 individuals with affective disorders recruited throughout 
the UK over a 10 year period between January 2005 and December 2014, and to 
newly recruited individuals from January 2015 onwards. 
 
2. Methods 
 
2.1. Participants 
BDRN is an ongoing research programme into the genetic and environmental 
aetiology of bipolar disorder and related affective dis-orders. Participants are 
recruited throughout the UK via NHS services and advertisements through patient 
support organisations, such as Bipolar UK (www.bipolaruk.org.uk). Inclusion criteria 
are: (i) aged 18 years or over at participation; (ii) able to provide written informed 
consent; (iii) meet DSM-IV criteria (American Psychiatric Association, 2000) for major 
affective disorder; and (iv) onset of mood symptoms before the age of 65 years. 
Best-estimate lifetime diagnoses are made according to DSM-IV criteria based on 
interview using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN; 
Wing et al., 1990) and review of psychiatric and general practice (primary care) case-
notes where available. 
 
2.2. Mood monitoring system - True Colours 
True Colours is an online mood monitoring system developed at the University of 
Oxford for clinical use in bipolar disorder (Bopp et al., 2010; McKnight et al., 2017). 
The True Colours system sends weekly email prompts to patients with an internet 
link to complete two validated and widely-used self-report questionnaires: the 16-
item Quick Inventory of Depressive Symptomatology patient-rated version (QIDS-SR; 
Rush et al., 2003) and the 5-item Altman Self-Rating Mania Scale (ASRM; Altman et 
al., 1997), which measure presence and severity of depressive and hypomanic/manic 
symptoms compatible with DSM-IV criteria over the preceding week respectively. 
The total scores and symptom scores are presented graphically, and can be viewed 
by participants and the clinical team via the secure True Colours website. Patients 
choose when to receive the weekly email prompt, and a re-minder email is sent after 
24 h if there is no response. 
Some adaptations to True Colours were necessary for use as a standalone research 
tool within a non-clinical environment. This involved the development of a 
comprehensive research participant user and help guide (both printable and online 
versions) which explained not only how to use True Colours but also how to interpret 
the output data. It was of crucial importance that BDRN participants understood that 
True Colours is a research tool and responses are not clinically monitored. 
Signposting that any concerns regarding mood symptoms should be expressed to 
healthcare teams through normal routes was added throughout the system. These 
adaptations were piloted on a small sample of 34 BDRN participants to ensure 
clarity, acceptability and practicality before large-scale roll out. The BDRN version of 
True Colours was ready for use in January 2015. 
 
2.3. Roll out of True Colours within BDRN 
UK National Health Service (NHS) Research Ethics Committee approval was obtained 
to use True Colours within BDRN (MREC/97/7/ 01). 
Past participants: BDRN participants who had been recruited over the previous 10 
year period (January 2005 to December 2014), had consented to ongoing contact 
from the research group, and for whom we had current contact details were invited 
to join True Colours using the following approaches: 
i) three postal invitations were sent over a period of 8 months. 
ii) email invitations were sent to those participants who had not responded t0 
the postal invitations and for whom we had an email address recorded. Non 
responders received a reminder email after two weeks. 
iii) we also promoted True Colours on the BDRN website and in the  annual       
BDRN newsletter that is sent by post to all participants who consent to 
receive it. 
 
New participants: All individuals newly recruited into BDRN from January 2015 
onwards were invited to join True Colours by a BDRN interviewer after taking part in 
the SCAN interview. 
All participants who replied positively to a True Colours invitation received an email 
with an internet link to register to True Colours. A reminder email was sent to 
participants who had not registered within two weeks of receiving their registration 
email. 
Participants who responded to an invitation by declining to join True Colours were 
invited to provide feedback on their reasons for declining. 
 
3. Results 
 
3.1. Mood monitoring uptake among BDRN past participants 
Postal invitations: Following three postal mail-outs to 4080/4285 BDRN participants 
recruited between January 2005 and December 2014 who met the inclusion criteria 
(consented to ongoing contact from the research group and known current contact 
details), 626 (15%) participants registered to True Colours. 
Email invitations: A subsequent email invitation was sent to a total of 1364 BDRN 
participants. Of these, 189 participants (14%) registered to True Colours. 
Therefore a total of 815 BDRN past participants registered for True Colours. 
Overall uptake rate among past participants who were invited to join True Colours 
was 20% (n = 815/4080). The proportion of BDRN past participants who registered to 
True Colours according to the total number of participants recruited to BDRN per 
year is shown in Fig. 1A. The years of recruitment in which the highest proportion of 
past participants joined True Colours were the three years directly preceding the 
invitation to join True Colours (21% in 2012; 22% in 2013; and, 27% in 2014). 
 
3.2. Mood monitoring uptake among new BDRN participants 
Since January 2015 to date, 46% (n = 160/346) of newly recruited BDRN participants 
have registered to True Colours. The proportion of new BDRN participants who 
registered for True Colours as a proportion of the total number of participants 
recruited to BDRN during each recruitment period is shown in Fig. 1B. More recently 
recruited participants were most likely to register to True Colours, with highest pro-
portion (61%) being in the most recent year compared to 32% in the first six months. 
The mean age of all BDRN participants who registered for True Colours was 49.7 
years (sd 11.8, range 18–82 years), and 71% was female. DSM-IV diagnosis of 
participants was: 60.5% bipolar I disorder; 37.1% bipolar II disorder; 1.3% 
schizoaffective disorder – bipolar type; and, 1.1% bipolar disorder not otherwise 
specified. The mean duration of illness was 29.7 years (sd 11.6, range 4–60 years), 
and nearly two thirds (66.0%) had been admitted to hospital for psychiatric 
treatment at least once during the course of their illness. 
 
3.3. Length of engagement with mood monitoring 
To date, the range of number of weeks of True Colours data provided by each 
participant is 1–165, with mean number of weeks 58 (standard deviation (sd) 48.4, 
median 46.5). These figures include all BDRN True Colours users, including new users 
who have only had the opportunity to contribute data for a few weeks. Fig. 2 shows 
the percentage of participants who have provided at least 4, 12, 26 and 52 weeks 
data as a proportion of those who have had the opportunity to complete for that 
number of weeks. Among past participants, 91%(734/815) completed at least four 
weeks, 78% (637/815) at least 12 weeks, 65% (533/815) at least 26 weeks and 51% 
(413/808) at least 52 weeks data. Among new participants, 92% (133/144) 
completed at least four weeks, 82% (116/141) at least 12 weeks, 54% (76/124) at 
least 26 weeks and 44% (40/91) at least 52 weeks data. There was no significant 
difference between the proportion of past and new participants completing for each 
length of time. 
 
 
 
 
 
 
  
 
3.4. Comparison of participants who did / did not register for mood monitoring 
There was no significant difference in the sex distribution or age at interview of 
BDRN participants who registered for True Colours com-pared to those who did not 
register. There was a significantly higher proportion of individuals with a DSM-IV 
diagnosis of bipolar II disorder who registered compared to individuals who did not 
register (37% vs 29% respectively, p < 0.001). 
3.5. Feedback from participants declining to join mood monitoring 
A total of 123 BDRN participants declined the invitation to join True Colours. Of 
these, 108 provided feedback on their reasons for declining, which we coded into 
categories (see Table 1). 
 
4. Discussion 
 
We have demonstrated that large-scale electronic longitudinal mood monitoring in 
affective disorders for research purposes is feasible. One in five of our large sample 
of past participants registered for True Colours, and just under half of newly 
recruited participants registered. Very few participants who engaged with mood 
monitoring did so for less than one month (<10%), the majority remained engaged 
for much longer with the mean length of engagement to date being over one year 
(58 weeks). Some participants have already contributed data for over three years 
(maximum period to date is 165 weeks) and continue to do so. 
It is evident that newly recruited participants who were invited to join True Colours 
at the same time they were recruited into BDRN were the most likely to register, 
which is likely because they were invited to participate in person and therefore had 
the opportunity to discuss True Colours with a BDRN researcher face-to-face. Among 
both past and new participants the most recent recruits were more likely to join True 
Colours with the highest uptake being among new participants recruited in the 
preceding year (61%). We suggest this may be due to how connected participants 
feel to the research programme and research team, as we find a similar pattern of 
engagement with other new studies within the BDRN research programme. The 
particularly large increase in participation rate over time among the new BDRN 
participants is likely due to increased awareness about BDRN True Colours through 
publicity via our website and newsletters, and via the UK support charity, Bipolar UK. 
For example, some participants report joining BDRN specifically to join True Colours, 
and we have observed that this peaks following national publicity, such as a Bipolar 
UK on-line blog written by a BDRN True Colours user. There was no significant 
difference in the length of engagement with mood monitoring between previously 
recruited and newly recruited participants – approximately half in both groups 
remained engaged after one year. 
While we did not find any evidence to suggest that BDRN participants who sign-up 
for mood monitoring are demographically different from those who do not, we did 
find that significantly more True Colours participants had a diagnosis of bipolar II 
disorder (37%) than those who did not sign-up (29%). Reasons for this are currently 
unclear, although higher levels of affective instability among our bipolar II 
participants (Marwaha et al., 2016) could mean that this group feels mood 
monitoring is particularly relevant for them. The representativeness of research 
participants who engage with electronic longitudinal measures must continue to be 
examined. 
The feedback from participants who declined to register for mood monitoring shows 
that the most common reason for declining was feeling it would not be personally 
relevant, and the most frequent ex-planation for this was stability of mood. We have 
been able to address this in our recruitment materials by explaining that we are 
interested in even very subtle changes in mood, and we will monitor whether this 
seems to address potential participant's concerns. Other reasons given for declining 
are expected and understandable, for example, concerns about required 
commitment and no internet access. It is of note that almost 1 in 5 participants who 
provided a reason for declining said they were concerned that longitudinal 
monitoring may adversely affect their mood. This possibility could be explored with 
participants who are or have previously engaged with mood monitoring. 
A limitation of the methods we have reported here in relation to the past BDRN 
participants is that they may not be generalisable to all research cohorts. We keep in 
at least annual contact with BDRN participants by means of a research newsletter 
and requests to complete questionnaires. Other existing cohorts who have less or 
more ongoing contact with the research team may have worse or better uptake 
rates for online longitudinal mood monitoring systems. We also note that the 
reasons given for not registering for True Colours were from participants who 
actively declined to register, and therefore may not be representative of participants 
who simply did not respond to invitations to register. 
The real-time longitudinal participant-reported data we continue to obtain using 
True Colours in our large BDRN sample is unique and valuable for studying 
naturalistic mood variability and illness trajectory in affective disorders, including 
potential triggers and early warning signs of illness episodes as well as how mood 
changes with other factors that vary over time, for example, sleep patterns and 
menstrual cycle. There is also potential to incorporate other important aspects of 
mood disorders that would benefit from longitudinal monitoring, such as adherence 
to medication (Pompili et al., 2013). Other mood disorder research cohorts should 
consider incorporating longitudinal real-time remote capture of mood as we have 
demonstrated that it is possible to engage participants in mood monitoring for 
research purposes without clinical feedback. Future research may maximise 
participation by focusing on personal face-to-face invitations to prospectively 
recruited participants. 
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